The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective
Open accessAbstract
Herpes zoster (HZ) is primarily a disease of nerve tissue but the acute and longer-term manifestations require multidisciplinary knowledge and involvement in their management. Complications may be dermatological (e.g. secondary bacterial infection), neurological (e.g. long-term pain, segmental paresis, stroke), ophthalmological (e.g. keratitis, iridocyclitis, secondary glaucoma) or visceral (e.g. pneumonia, hepatitis). The age-related increased incidence of HZ and its complications is thought to be a result of the decline in cell-mediated immunity (immunosenescence), higher incidence of comorbidities with age and social-environmental changes. Individuals who are immunocompromised as a result of disease or therapy are also at increased risk, independent of age. HZ and its complications (particularly postherpetic neuralgia) create a significant burden for the patient, carers, healthcare systems and employers. Prevention and treatment of HZ complications remain a therapeutic challenge despite recent advances. This is an overview of the multidisciplinary implications and management of HZ in which the potential contribution of vaccination to reducing the incidence HZ and its complications are also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
Finnerup, N. B., Attal, N., Haroutounian, S., McNicol, E., Baron, R., Dworkin, R. H., Gilron, I., Haanpää, M., Hansson, P., Jensen, T. S., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70251-0 · Cited by 3,980 · cited 1×
“Topical application of lidocaine patches and treatment with 8% capsaicin patches may provide relief for some patients and avoids systemic side effects [Johnson and Rice, 2014; Finnerup et al. 2015].”
BackgroundA Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults
Oxman, M. N., Levin, M. J., Johnson, G. R., Schmader, K. E., Straus, S. E., Gelb, L. D., Arbeit, R. D., Simberkoff, M. S., Gershon, A. A., Davis, L. E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051016 · Cited by 2,412
The Nature of Herpes Zoster: A Long-Term Study and a New Hypothesis
Hope-Simpson, R. E. (1965) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576505800106 · Cited by 1,386
Arvin, A. M. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.3.361 · Cited by 1,162
Harpaz, R., Ortega‐Sanchez, I. R., & Seward, J. F. (2008) · PubMed · Cited by 1,037
Systematic review of incidence and complications of herpes zoster: towards a global perspective
Kawai, K., Gebremeskel, B. G., & Acosta, C. J. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-004833 · Cited by 938
Population-Based Study of Herpes Zoster and Its Sequelae
RAGOZZINO, M. W., MELTON, L. J., KURLAND, L. T., CHU, C. P., & PERRY, H. O. (1982) · Medicine · doi:10.1097/00005792-198209000-00003 · Cited by 926
Gnann, J. W., & Whitley, R. J. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp013211 · Cited by 781
Cohen, J. I. (2013) · New England Journal of Medicine · doi:10.1056/nejmcp1302674 · Cited by 734
Johnson, R. W., & Rice, A. S. C. (2014) · New England Journal of Medicine · doi:10.1056/nejmcp1403062 · Cited by 566
Self-citationHerpes Zoster OphthalmicusNatural History, Risk Factors, Clinical Presentation, and Morbidity
LIESEGANG, T. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2007.10.009 · Cited by 471
Infectious Encephalitis in France in 2007: A National Prospective Study
Mailles, A., & Stahl, J. (2009) · Clinical Infectious Diseases · doi:10.1086/648419 · Cited by 431
Efficacy, Safety, and Tolerability of Herpes Zoster Vaccine in Persons Aged 50-59 Years
Schmader, K. E., Levin, M. J., Gnann, J. W., McNeil, S. A., Vesikari, T., Betts, R. F., Keay, S., Stek, J. E., Bundick, N. D., Su, S.-C., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir970 · Cited by 430
Herpes Zoster (Shingles) and Postherpetic Neuralgia
Sampathkumar, P., Drage, L. A., & Martin, D. P. (2009) · Mayo Clinic Proceedings · doi:10.4065/84.3.274 · Cited by 429
The impact of herpes zoster and post-herpetic neuralgia on quality-of-life
Johnson, R. W., Bouhassira, D., Kassianos, G., Leplège, A., Schmader, K. E., & Weinke, T. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-37 · Cited by 404
Self-citationThe global epidemiology of herpes zoster
Yawn, B. P., & Gilden, D. (2013) · Neurology · doi:10.1212/wnl.0b013e3182a3516e · Cited by 347
Brisson, M., Gay, N. J., Edmunds, W. J., & Andrews, N. J. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00180-9 · Cited by 341
Immune Responses to Varicella-Zoster in the Aged
Burke, B. L. (1982) · Archives of Internal Medicine · doi:10.1001/archinte.1982.00340150091017 · Cited by 295
Antiviral treatment for preventing postherpetic neuralgia
Chen, N., Li, Q., Yang, J., Zhou, M., Zhou, D., & He, L. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006866.pub3 · Cited by 289
Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom
GAUTHIER, A., BREUER, J., CARRINGTON, D., MARTIN, M., & RÉMY, V. (2009) · Epidemiology and Infection · doi:10.1017/s0950268808000678 · Cited by 287
Zhang, J., Xie, F., Delzell, E., Chen, L., Winthrop, K. L., Lewis, J. D., Saag, K. G., Baddley, J. W., & Curtis, J. R. (2012) · JAMA · doi:10.1001/jama.2012.7304 · Cited by 283
Smitten, A. L., Choi, H. K., Hochberg, M. C., Suissa, S., Simon, T. A., Testa, M. A., & Chan, K. A. (2007) · Arthritis Care & Research · doi:10.1002/art.23112 · Cited by 281
Helgason, S. (2000) · BMJ · doi:10.1136/bmj.321.7264.794 · Cited by 268
Quantification of risk factors for herpes zoster: population based case-control study
Forbes, H. J., Bhaskaran, K., Thomas, S. L., Smeeth, L., Clayton, T., & Langan, S. M. (2014) · BMJ · doi:10.1136/bmj.g2911 · Cited by 267
Oral Acyclovir in the Treatment of Acute Herpes Zoster Ophthalmicus
Cobo, L. M., Foulks, G. N., Liesegang, T., Lass, J., Sutphin, J. E., Wilhelmus, K., Jones, D. B., Chapman, S., Segreti, A. C., & King, D. H. (1986) · Ophthalmology · doi:10.1016/s0161-6420(86)33678-9 · Cited by 252
Similar herpes zoster incidence across Europe: results from a systematic literature review
Pinchinat, S., Cebrián-Cuenca, A. M., Bricout, H., & Johnson, R. W. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-170 · Cited by 245
Self-citationHerpes Zoster Vaccine in Older Adults and the Risk of Subsequent Herpes Zoster Disease
Tseng, H. F. (2011) · JAMA · doi:10.1001/jama.2010.1983 · Cited by 239
Opstelten, W. (2002) · Family Practice · doi:10.1093/fampra/19.5.471 · Cited by 228
Herpes Zoster Recurrences More Frequent Than Previously Reported
Yawn, B. P., Wollan, P. C., Kurland, M. J., St. Sauver, J. L., & Saddier, P. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0618 · Cited by 227
Winthrop, K. L., Baddley, J. W., Chen, L., Liu, L., Grijalva, C. G., Delzell, E., Beukelman, T., Patkar, N. M., Xie, F., Saag, K. G., et al. (2013) · JAMA · doi:10.1001/jama.2013.1099 · Cited by 223
Leung, J., Harpaz, R., Molinari, N.-A., Jumaan, A., & Zhou, F. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq077 · Cited by 208
Langan, S. M., Smeeth, L., Margolis, D. J., & Thomas, S. L. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001420 · Cited by 203
Incidence of herpes zoster in patients with altered immune function
Chen, S.-Y., Suaya, J. A., Li, Q., Galindo, C. M., Misurski, D., Burstin, S., & Levin, M. J. (2014) · Infection · doi:10.1007/s15010-013-0550-8 · Cited by 198
Increased risk of herpes zoster among 108 604 patients with inflammatory bowel disease
Long, M. D., Martin, C., Sandler, R. S., & Kappelman, M. D. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12182 · Cited by 186
Toyama, N., Shiraki, K., & and Members of the Society of the Miyazaki Prefecture Dermatologists (2009) · Journal of Medical Virology · doi:10.1002/jmv.21599 · Cited by 176
Gialloreti, L. E., Merito, M., Pezzotti, P., Naldi, L., Gatti, A., Beillat, M., Serradell, L., di Marzo, R., & Volpi, A. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-230 · Cited by 174
Self-citationHata, A., Kuniyoshi, M., & Ohkusa, Y. (2011) · Infection · doi:10.1007/s15010-011-0162-0 · Cited by 170
Bouhassira, D., Chassany, O., Gaillat, J., Hanslik, T., Launay, O., Mann, C., Rabaud, C., Rogeaux, O., & Strady, C. (2012) · Pain · doi:10.1016/j.pain.2011.10.026 · Cited by 163
Self-citationWareham David, W., Breuer, J., 郑厚峰, & 张学军 (2007) · doi:10.3760/cma.j.issn.1007-9742.2007.06.122 · Cited by 162
Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales
van Hoek, A. J., Gay, N., Melegaro, A., Opstelten, W., & Edmunds, W. J. (2009) · Vaccine · doi:10.1016/j.vaccine.2008.12.024 · Cited by 156
Wang, K., Lau, T. Y., Morales, M., Mont, E. K., & Straus, S. E. (2005) · Journal of Virology · doi:10.1128/jvi.79.22.14079-14087.2005 · Cited by 153
Examination of Links Between Herpes Zoster Incidence and Childhood Varicella Vaccination
Hales, C. M., Harpaz, R., Joesoef, M. R., & Bialek, S. R. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-11-201312030-00006 · Cited by 151
Impact of Varicella Vaccine on Varicella-Zoster Virus Dynamics
Schmid, D. S., & Jumaan, A. O. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00031-09 · Cited by 139
de Melker, H. E., Berbers, G. A. M., Hahné, S., Rümke, H. C., van den Hof, S., de Wit, G. A., & Boot, H. J. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.02.017 · Cited by 138
Predictors of Postherpetic Neuralgia Among Patients With Herpes Zoster: A Prospective Study
Drolet, M., Brisson, M., Schmader, K. E., Levin, M. J., Johnson, R. W., Oxman, M. N., Patrick, D. M., Camden, S., & Mansi, J. A. (2010) · Journal of Pain · doi:10.1016/j.jpain.2010.02.020 · Cited by 128
Self-citationOgunjimi, B., Damme, P. V., & Beutels, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066485 · Cited by 123
Stein, A., Britt, H. C., Harrison, C. M., Conway, E. L., Cunningham, A. L., & MacIntyre, C. R. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.11.012 · Cited by 121
Herpes zoster pathogenesis and cell-mediated immunity and immunosenescence.
Oxman, M. N. (2009) · PubMed · Cited by 119
A population based study of the epidemiology of Herpes Zoster and its complications
Weitzman, D., Shavit, O., Stein, M., Cohen, R., Chodick, G., & Shalev, V. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.06.016 · Cited by 116
Modeling the Effects of Varicella Vaccination Programs on the Incidence of Chickenpox and Shingles
Schuette, M. C., & Hethcote, H. W. (1999) · Bulletin of Mathematical Biology · doi:10.1006/bulm.1999.0126 · Cited by 113
The Epidemiology of Herpes Zoster in Patients with Newly Diagnosed Cancer
Habel, L. A., Ray, G. T., Silverberg, M. J., Horberg, M. A., Yawn, B. P., Castillo, A., Quesenberry, C. P., Li, Y., Saddier, P., & Tran, T. N. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0815 · Cited by 112
de Broucker, T., Mailles, A., Chabrier, S., Morand, P., & Stahl, J. ‐. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03705.x · Cited by 111
Disease burden and epidemiology of herpes zoster in pre-vaccine Taiwan
Lin, Y.-H., Huang, L., Chang, I., Tsai, F., Lu, C., Shao, P., & Chang, L. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.11.029 · Cited by 89
Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany
Ultsch, B., Köster, I., Reinhold, T., Siedler, A., Krause, G., Icks, A., Schübert, I., & Wichmann, O. (2012) · The European Journal of Health Economics · doi:10.1007/s10198-012-0452-1 · Cited by 89
Herpes Zoster Among Persons Living With HIV in the Current Antiretroviral Therapy Era
Blank, L. J., Polydefkis, M. J., Moore, R. D., & Gebo, K. A. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318266cd3c · Cited by 85
Tanuseputro, P., Zagorski, B., Chan, K. J., & Kwong, J. C. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.09.024 · Cited by 76
Herpes zoster: Burden of disease in France
Chiappe, S. G., Sarazin, M., Turbelin, C., Lasserre, A., Pelat, C., Bonmarin, I., Chosidow, O., Blanchon, T., & Hanslik, T. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.09.074 · Cited by 76
Herpes Zoster and Postherpetic Neuralgia in Older Adults
Schmader, K. E. (2007) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2007.03.003 · Cited by 69
Herpes zoster overview: natural history and incidence.
Weaver, B. A. (2009) · PubMed · Cited by 68
Acute retinal necrosis in the course of AIDS
Batisse, D., Eliaszewicz, M., Zazoun, L., Baudrimont, M., Pialoux, G., & Dupont, B. (1996) · AIDS · doi:10.1097/00002030-199601000-00008 · Cited by 68
O’Connor, K., & Paauw, D. S. (2013) · Medical Clinics of North America · doi:10.1016/j.mcna.2013.02.002 · Cited by 67
Herpes Zoster Pain, Postherpetic Neuralgia, and Quality of Life in the Elderly
Pickering, G. P., & Leplège, A. (2010) · Pain Practice · doi:10.1111/j.1533-2500.2010.00432.x · Cited by 65
Burden of herpes zoster in the UK: findings from the zoster quality of life (ZQOL) study
Gater, A., Abetz‐Webb, L., Carroll, S., Mannan, A., Serpell, M. G., & Johnson, R. W. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-402 · Cited by 62
Self-citationCognitive Function in Older Patients with Postherpetic Neuralgia
Pickering, G. P., Pereira, B., Clère, F., Sorel, M., de Montgazon, G. B., Navez, M., Picard, P., Roux, D., Morel, V., Salimani, R., et al. (2013) · Pain Practice · doi:10.1111/papr.12079 · Cited by 62
Studahl, M., Petzold, M., & Cassel, T. N. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-586 · Cited by 61
Herpes Zoster Ophthalmicus in Olmsted County, Minnesota
Severson, E. A. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.3.386 · Cited by 58
Clinical manifestations of herpes zoster
Oxman, M. N. (2000) · Cambridge University Press eBooks · doi:10.1017/cbo9780511601194.015 · Cited by 53
Impaired Modulation of Pain in Patients with Postherpetic Neuralgia
Pickering, G. P., Pereira, B., Dufour, E., Soule-Sonneville, S., & Dubray, C. (2014) · Pain Research and Management · doi:10.1155/2014/507947 · Cited by 52
van Lier, A., van Hoek, A. J., Opstelten, W., Boot, H. J., & de Melker, H. E. (2010) · BMC Health Services Research · doi:10.1186/1472-6963-10-237 · Cited by 52
Weinke, T., Edte, A., Schmitt, S., & Lukas, K. (2010) · Journal of Public Health · doi:10.1007/s10389-010-0323-0 · Cited by 51
Self-citationAnnemans, L., Bresse, X., Gobbo, C., & Papageorgiou, M. (2010) · Journal of Medical Economics · doi:10.3111/13696998.2010.502854 · Cited by 46
Moore, L., Rémy, V., Martin, M., Beillat, M., & McGuire, A. J. (2010) · Cost Effectiveness and Resource Allocation · doi:10.1186/1478-7547-8-7 · Cited by 45
Unmet need in the treatment of postherpetic neuralgia.
Sacks, G. M. (2013) · PubMed · Cited by 41
Bresse, X., Annemans, L., Preaud, E., Bloch, K., Duru, G., & Gauthier, A. (2013) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.13.19 · Cited by 40
Public Awareness and Knowledge of Herpes Zoster: Results of a Global Survey
Paek, E., & Johnson, R. W. (2009) · Gerontology · doi:10.1159/000240046 · Cited by 39
Self-citationCost-effectiveness of vaccination of the elderly against herpes zoster in The Netherlands
de Boer, P. T., Pouwels, K. B., Cox, J. M., Hak, E., Wilschut, J., & Postma, M. J. (2013) · Vaccine · doi:10.1016/j.vaccine.2012.12.067 · Cited by 36
Statement on Seasonal Influenza Vaccine for 2013–2014
(2013) · Canada Communicable Disease Report · doi:10.14745/ccdr.v39i00a04 · Cited by 36
Szucs, T. D., Kressig, R. W., Papageorgiou, M., Kempf, W., Michel, J., Fendl, A., & Bresse, X. (2011) · Human Vaccines · doi:10.4161/hv.7.7.15573 · Cited by 35
Self-citationUltsch, B., Weidemann, F., Reinhold, T., Siedler, A., Krause, G., & Wichmann, O. (2013) · BMC Health Services Research · doi:10.1186/1472-6963-13-359 · Cited by 35
Esteban-Vasallo, M. D., Gil-Prieto, R., Domínguez‐Berjón, M. F., Astray‐Mochales, J., & de Miguel, Á. G. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.09.035 · Cited by 29
Vaccination against herpes zoster in developed countries
Drolet, M., Oxman, M. N., Levin, M. J., Schmader, K. E., Johnson, R. W., Patrick, D. M., Mansi, J. A., & Brisson, M. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.23491 · Cited by 27
Self-citationWeinke, T., Glogger, A., Bertrand, I., & Lukas, K. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/749698 · Cited by 26
Self-citationPreventing Herpes Zoster through Vaccination
Gelb, L. D. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2007.10.015 · Cited by 23
Shearer, K., Maskew, M., Ajayi, T., Berhanu, R. H., Majuba, P., Sanne, I., & Fox, M. P. (2014) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2013.10.016 · Cited by 21
Options for treating postherpetic neuralgia in the medically complicated patient
Bruckenthal, P., & Barkin, R. L. (2013) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s47138 · Cited by 20
Perceptions of herpes zoster and attitudes towards zoster vaccination among 50-65-year-old Danes.
Mortensen, G. L. (2011) · PubMed · Cited by 19
Early antiviral treatment fails to completely prevent herpes-related pain
Rabaud, C., Rogeaux, O., Launay, O., Strady, C., Mann, C., Chassany, O., Bouhassira, D., & Gaillat, J. (2013) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2013.07.012 · Cited by 12
Self-citation
Cited by
Inflammatory Response in the CNS: Friend or Foe?
Sochocka, M., Diniz, B. S., & Leszek, J. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0297-1 · Cited by 573
“Decline in cell-mediated immunity may in turn cause the age-related increased incidence of Herpes zoster (varicella zoster virus, VZV) and its complications in the elderly which is a worldwide growing problem for patient, cares, healthcare systems, and employers [25].”
Background
Metadata
- Authors
- Johnson, R. W., Alvarez-Pasquin, M.-J., Bijl, M., Franco, E., Gaillat, J., Clara, J. G., Labetoulle, M., Michel, J.-P., Naldi, L., Sanmarti, L. S., & Weinke, T.
- Venue
- Therapeutic Advances in Vaccines
- Publisher
- SAGE Publications
- Published
- 2015-07
- Volume
- 3
- Issue
- 4
- Pages
- 109-120
- ISSN
- 2051-0136 (ISSN-L)
- 2051-0144
- OpenAlex
- W2180178398
- Cited by
- 288
- References
- 87
- FWCI
- 11.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.